Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Epilepsies of early childhood are frequently resistant to therapy and often associated with cognitive and behavioural comorbidity. Aetiology focused precision medicine, notably gene-based therapies, may prevent seizures and comorbidities. Epidemiological data utilizing modern diagnostic techniques including whole genome sequencing and neuroimaging can inform diagnostic strategies and therapeutic trials. We present a 3-year, multicentre prospective cohort study, involving all children under 3 years of age in Scotland presenting with epilepsies. We used two independent sources for case identification: clinical reporting and EEG record review. Capture-recapture methodology was then used to improve the accuracy of incidence estimates. Socio-demographic and clinical details were obtained at presentation, and 24 months later. Children were extensively investigated for aetiology. Whole genome sequencing was offered for all patients with drug-resistant epilepsy for whom no aetiology could yet be identified. Multivariate logistic regression modelling was used to determine associations between clinical features, aetiology, and outcome. Three hundred and ninety children were recruited over 3 years. The adjusted incidence of epilepsies presenting in the first 3 years of life was 239 per 100 000 live births [95% confidence interval (CI) 216–263]. There was a socio-economic gradient to incidence, with a significantly higher incidence in the most deprived quintile (301 per 100 000 live births, 95% CI 251–357) compared with the least deprived quintile (182 per 100 000 live births, 95% CI 139–233), χ2 odds ratio = 1.7 (95% CI 1.3–2.2). The relationship between deprivation and incidence was only observed in the group without identified aetiology, suggesting that populations living in higher deprivation areas have greater multifactorial risk for epilepsy. Aetiology was determined in 54% of children, and epilepsy syndrome was classified in 54%. Thirty-one per cent had an identified genetic cause for their epilepsy. We present novel data on the aetiological spectrum of the most commonly presenting epilepsies of early childhood. Twenty-four months after presentation, 36% of children had drug-resistant epilepsy (DRE), and 49% had global developmental delay (GDD). Identification of an aetiology was the strongest determinant of both DRE and GDD. Aetiology was determined in 82% of those with DRE, and 75% of those with GDD. In young children with epilepsy, genetic testing should be prioritized as it has the highest yield of any investigation and is most likely to inform precision therapy and prognosis. Epilepsies in early childhood are 30% more common than previously reported. Epilepsies of undetermined aetiology present more frequently in deprived communities. This likely reflects increased multifactorial risk within these populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common DEE syndrome is Infantile Epileptic Spasms Syndrome (IESS) with an incidence of 30.7 in 100,000 individuals (95% CI 22.9-40.2) to 48.9 in 100,000 individuals (95% CI 37.0-64.7);~27% of IESS have a structural aetiology 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Incidence estimates have been reported for many DEE syndromes; however, around one-third of patients cannot be classified as having a specific syndrome 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In comparison, the estimated incidence of all epilepsies presenting under 3 years was 239 in 100,000 (95% CI 216-263) in a prospective study in Scotland, UK, with DEEs accounting for 86.1 in 100,000 (95% CI 72.7-101.3)children 9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Self-citationKwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073 · cited 1×
“On a population level, the highest age-specific incidences of 460 per 100 000 are observed in children under 5 years of age and in adults over 65 years of age.(9) A significant proportion (35%) of children presenting with epilepsies in the first 3 years of life develop drugresistant seizures.”
BackgroundTrial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711 · cited 1×
“Precise clinical classification of epilepsy syndrome, and identification of a genetic aetiology, helps guide therapeutic strategy, exemplified by randomized controlled trials in Lennox-Gastaut syndrome,(4,5) and Dravet syndrome.(6,7) For the individually rare but severe epilepsies caused by large effect mutations in a…”
BackgroundEffect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015
Self-citationThiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Self-citationState of the Art Review: Poverty and the Developing Brain
Johnson, S. B., Riis, J. L., & Noble, K. G. (2016) · Pediatrics · doi:10.1542/peds.2015-3075 · Cited by 624
Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study
Aaberg, K. M., Gunnes, N., Bakken, I. J., Lund Søraas, C., Berntsen, A., Magnus, P., Lossius, M. I., Stoltenberg, C., Chin, R., & Surén, P. (2017) · Pediatrics · doi:10.1542/peds.2016-3908 · Cited by 503
Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459 · cited 3×
“Since PRRT2-associated epilepsy is associated with a good outcome in nearly all cases, there is little selection pressure on this gene, and in 71% of cases in our study the variant was inherited.(17) It is possible that epilepsy-associated PRRT2 variants are more prevalent in the Scottish population than other populat…”
BackgroundMethodSelf-citationLagae, L., Sullivan, J., Knupp, K., Laux, L., Polster, T., Nikanorova, M., Devinsky, O., Cross, J. H., Guerrini, R., Talwar, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32500-0 · Cited by 384 · cited 2×
“the recently repurposed drug fenfluramine is highly encouraging in this condition.(7) For parents of children affected by severe epi-”
BackgroundGlobal cognitive function in children with epilepsy: A community‐based study
Berg, A. T., Langfitt, J. T., Testa, F. M., Levy, S. R., DiMario, F., Westerveld, M., & Kulas, J. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01461.x · Cited by 373
Camfield, C. S., Camfield, P. R., Gordon, K., Wirrell, E., & Dooley, J. M. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00506.x · Cited by 320
Lindy, A. S., Stosser, M. B., Butler, E., Downtain‐Pickersgill, C., Shanmugham, A., Retterer, K., Brandt, T., Richard, G., & McKnight, D. A. (2018) · Epilepsia · doi:10.1111/epi.14074 · Cited by 305
O'Callaghan, F. J. K., Edwards, S. W., Alber, F. D., Hancock, E., Johnson, A. L., Kennedy, C. R., Likeman, M., Lux, A. L., Mackay, M., Mallick, A. A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30294-0 · Cited by 289 · cited 1×
“portant that therapeutic trials look at more holistic outcomes than purely seizure control,(37) as exemplified by the ICISS trial for children with infantile spasms syndrome.(43) Gene-corrective therapies”
BackgroundThe evolving spectrum of PRRT2-associated paroxysmal diseases
Ebrahimi-Fakhari, D., Saffari, A., Westenberger, A., & Klein, C. (2015) · Brain · doi:10.1093/brain/awv317 · Cited by 270 · cited 1×
“Arg217Profs*8, has also been frequently reported in other populations.(34,35) We think the more likely explanation for the high incidence of PRRT2 variants in our study is that we present an unselected cohort of children with early onset epilepsies, which includes those with mild phenotypes.”
ResultWirrell, E. C., Grossardt, B. R., Wong-Kisiel, L. C. L., & Nickels, K. C. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.03.009 · Cited by 219
O'Callaghan, F. J. K., Edwards, S. W., Alber, F. D., Cortina Borja, M., Hancock, E., Johnson, A. L., Kennedy, C. R., Likeman, M., Lux, A. L., Mackay, M. T., et al. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30244-x · Cited by 167 · cited 1×
“Early recognition and treatment of infantile spasms is important since there is a significant positive correlation between treatment delay and adverse outcome.(36) The strongest determinant of outcomes 24 months after presentation was the identification of an aetiology.”
Backgroundde Lange, I. M., Gunning, B., Sonsma, A. C. M., van Gemert, L., van Kempen, M., Verbeek, N. E., Nicolai, J., Knoers, N. V. A. M., Koeleman, B. P. C., & Brilstra, E. H. (2018) · Epilepsia · doi:10.1111/epi.14191 · Cited by 161
Parental anxiety and quality of life in children with epilepsy
Williams, J., Steel, C., Sharp, G. B., DelosReyes, E., Phillips, T., Bates, S., Lange, B. M., & Griebel, M. L. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00159-8 · Cited by 153
Polygenic burden in focal and generalized epilepsies
Leu, C., Stevelink, R., Smith, A. W., Goleva, S. B., Kanai, M., Ferguson, L., Campbell, C., Kamatani, Y., Okada, Y., Sisodiya, S. M., et al. (2019) · Brain · doi:10.1093/brain/awz292 · Cited by 151
Epilepsy and developmental disorders: Next generation sequencing in the clinic
Symonds, J. D., & McTague, A. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.008 · Cited by 151
Self-citationDepression, anxiety and quality of life in parents of children with epilepsy
Lv, R., Wu, L., Jin, L., Lü, Q., Wang, M., Qu, Y., & Liu, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01184.x · Cited by 141
Wirrell, E., Wong‐Kisiel, L., Mandrekar, J., & Nickels, K. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03562.x · Cited by 138 · cited 2×
“Previous estimates for the incidence of epilepsies in the first year of life have all involved smaller denominator populations than the present study, and figures have ranged between 83 per 100 000 and 144 per 100 000 In a 30-year retrospective review of a cohort within the Rochester Epidemiology study (1980– 2009, n…”
BackgroundComorbidities and predictors of health‐related quality of life in Dravet syndrome
Brunklaus, A., Dorris, L., & Zuberi, S. M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03129.x · Cited by 123
Self-citationPRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine
Marini, C., Conti, V., Mei, D., Battaglia, D., Lettori, D., Losito, E., Bruccini, G., Tortorella, G., & Guerrini, R. (2012) · Neurology · doi:10.1212/wnl.0b013e3182752ca2 · Cited by 117
Gaily, E., Lommi, M., Lapatto, R., & Lehesjoki, A. (2016) · Epilepsia · doi:10.1111/epi.13514 · Cited by 112
Investigation of global developmental delay
McDonald, L. A. B. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2005.078147 · Cited by 105 · cited 1×
“GDD was defined as delay 52 standard deviations (SD) below the mean in two or more domains of development (gross motor, fine motor, speech and language, social), as perceived by the managing physician.(15) Epilepsy was classified as per the 2017 International League Against Epilepsy (ILAE) position paper on classifica…”
BackgroundA population‐based study of newly diagnosed epilepsy in infants
Eltze, C. M., Chong, W. K., Cox, T., Whitney, A., Cortina‐Borja, M., Chin, R. F. M., Scott, R. C., & Cross, J. H. (2013) · Epilepsia · doi:10.1111/epi.12046 · Cited by 90
Social deprivation and prevalence of epilepsy and associated health usage
Morgan, C. L. I. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.13 · Cited by 85
Huang, L.-T. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00008 · Cited by 81
Epilepsy and deprivation, a data linkage study
Pickrell, W. O., Lacey, A., Bodger, O. G., Demmler, J. C., Thomas, R. H., Lyons, R. A., Smith, P. E. M., Rees, M. I., & Kerr, M. (2015) · Epilepsia · doi:10.1111/epi.12942 · Cited by 74 · cited 1×
“The fact that socio-economic status is associated with epilepsy incidence at such an early stage in life supports the conclusion that this trend is observed because low socio-economic status is a risk factor for epilepsies (social causation) rather than because epilepsies influence socioeconomic prospects (social drif…”
BackgroundCassano, P. A., Koepsell, T. D., & Farwell, J. R. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115681 · Cited by 73
Incorporating epilepsy genetics into clinical practice: a 360°evaluation
Oates, S., Tang, S. S., Rosch, R. E., Lear, R., Hughes, E., Williams, R. E., Larsen, L. H. G., Hao, Q., Dahl, H. A., Møller, R. S., et al. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0052-9 · Cited by 68 · cited 1×
“Recent advances in both neuroimaging and genetic testing have resulted in a significant increase in the proportion of epilepsies that can be aetiologically resolved, particularly among epilepsies that begin in early childhood.(3) Precise clinical classification of epilepsy syndrome, and identification of a genetic aet…”
BackgroundTackling Epilepsy With High-definition Precision Medicine: A Review
Kearney, H., Byrne, S., Cavalleri, G. L., & Delanty, N. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2384 · Cited by 62
Novel therapies for epilepsy in the pipeline
Mesraoua, B., Deleu, D., Kullmann, D. M., Shetty, A. K., Boon, P., Perucca, E., Mikati, M. A., & Asadi‐Pooya, A. A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.042 · Cited by 54 · cited 1×
“For the individually rare but severe epilepsies caused by large effect mutations in a single gene, gene-directed therapy is a realistic prospect.(8) The epilepsies have a high incidence in early childhood.”
BackgroundKurki, M. I., Saarentaus, E., Pietiläinen, O., Gormley, P., Lal, D., Kerminen, S., Torniainen-Holm, M., Hämäläinen, E., Rahikkala, E., Keski-Filppula, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08262-y · Cited by 51
Genetic therapies for inherited neuromuscular disorders
Scoto, M., Finkel, R. S., Mercuri, E. M., & Muntoni, F. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30140-8 · Cited by 45
Lawder, R., Whyte, B., Wood, R., Fischbacher, C., & Tappin, D. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023213 · Cited by 45
Morbidity and mortality of childhood- and adolescent-onset epilepsy: A controlled national study
Jennum, P., Pickering, L., Christensen, J., Ibsen, R., & Kjellberg, J. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.10.023 · Cited by 40 · cited 1×
“These individuals are at high risk of cognitive and behavioural comorbidity(11) and of early mortality.(12) Whilst early age of onset, poor seizure control, and developmental comorbidity are undoubtedly interrelated,(10) the causal nature of these relationships is not clear.”
BackgroundSaarentaus, E., Havulinna, A. S., Mars, N., Ahola‐Olli, A., Kiiskinen, T., Partanen, J., Ruotsalainen, S., Kurki, M., Urpa, L., Chen, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01026-z · Cited by 20
A Practical Definition of Epilepsy
Shin, D. J., Lee, B. I., & Song, H. K. (2016) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2016.3.2 · Cited by 8 · cited 1×
“The epilepsies are a group of conditions defined by an ‘enduring predisposition of the brain to generate epileptic seizures’.(1,2) Epilepsies result from diverse aetiologies, including structural brain lesions, as well as monogenic and polygenic variation.”
Background
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationPerucca, E., Perucca, P., White, H. S., & Wirrell, E. C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00151-5 · Cited by 305
International consensus on diagnosis and management of Dravet syndrome
Wirrell, E. C., Hood, V., Knupp, K. G., Meskis, M. A., Nabbout, R., Scheffer, I. E., Wilmshurst, J., & Sullivan, J. (2022) · Epilepsia · doi:10.1111/epi.17274 · Cited by 249
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationDonnan, A. M., Schneider, A. L., Russ-Hall, S., Churilov, L., & Scheffer, I. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207080 · Cited by 97
Metadata
- Authors
- Symonds, J. D., Elliott, K. S., Shetty, J., Armstrong, M., Brunklaus, A., Cutcutache, I., Diver, L. A., Dorris, L., Gardiner, S., Jollands, A., Joss, S., Kirkpatrick, M., McLellan, A., MacLeod, S., O’Regan, M., Page, M., Pilley, E., Pilz, D. T., Stephen, E., Stewart, K., Ashrafian, H., Knight, J. C., & Zuberi, S. M.
- Affiliations
- Royal Hospital for Children (GB)
- Centre for Human Genetics (GB)
- UCB Pharma (Belgium) (BE)
- UCB Pharma (United Kingdom) (GB)
- Queen Elizabeth University Hospital (GB)
- NHS Tayside (GB)
- University of Dundee (GB)
- Royal Aberdeen Children's Hospital (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-01
- Volume
- 144
- Issue
- 9
- Pages
- 2879-2891
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC8557326
- OpenAlex
- W3168961767
- Cited by
- 269
- References
- 44
- Citations by year
- 2026: 66 · 2025: 72 · 2024: 64 · 2023: 49 · 2022: 17
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Dravet Syndrome UK
- Epilepsy Research UK
- Glasgow Children’s Hospital Charity
- UCB Pharma
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- early childhood epilepsy, epilepsy incidence, socioeconomic deprivation, epilepsy etiology, drug-resistant epilepsy, global developmental delay, epilepsy syndromes, genetic epilepsy, whole genome sequencing, mark-recapture, epilepsy classification, Scotland, children under 3 years, gene therapy, precision medicine, neuroimaging, prospective cohort
- MeSH terms
- Drug Resistant Epilepsy, Child, Preschool, Epilepsy, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Retrospective Studies, Scotland, Socioeconomic Factors, Cohort Studies, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.